Cure My Disease

Don't miss your cure!

 Log in / Sign up

Syringe showdown: does a prefilled device deliver drug as well as a vial?

NCT ID NCT04194892

Completed Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study tests whether giving pegilodecakin (a biologic drug) via a prefilled syringe works the same as drawing it from a vial into a standard syringe. Healthy adults receive a single dose by each method, and researchers measure how fast the drug enters the bloodstream and how long it stays. The goal is to see if the prefilled syringe is a reliable alternative for future use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pegilodecakin
What this could lead to
If the prefilled syringe works as well as the vial, it could make dosing more convenient and reduce preparation errors.
What could go wrong
This is a small, early-phase study in healthy volunteers, so results may not predict effects in patients or real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULT SUBJECTS

Contacts and locations

Locations

  • PPD Phase 1 Clinic

    Austin, Texas, 78744, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.